Related Experiment Video

Updated: Sep 4, 2026

Assessing Changes in Volatile General Anesthetic Sensitivity of Mice after Local or Systemic Pharmacological Intervention
08:49

Assessing Changes in Volatile General Anesthetic Sensitivity of Mice after Local or Systemic Pharmacological Intervention

Published on: October 17, 2013

The dissociation of GM-CSF efficacy from toxicity according to route of administration: a pharmacodynamic study

J Cebon1, G J Lieschke, R W Bury

  • 1Melbourne Tumour Biology Branch, Ludwig Institute for Cancer Research, Vic., Australia.

British Journal of Haematology
|February 1, 1992
PubMed

Insights

Bacterially synthesized granulocyte-macrophage colony-stimulating factor (GM-CSF) showed improved efficacy when administered subcutaneously versus intravenously. Optimizing administration method can enhance GM-CSF

Area of Science:

  • Pharmacology
  • Biotechnology
  • Hematology

Background:

  • Granulocyte-macrophage colony-stimulating factor (GM-CSF) is crucial for hematopoiesis.
  • Bacterially synthesized GM-CSF offers a therapeutic option for various conditions.
  • Understanding its pharmacokinetics and pharmacodynamics is vital for optimizing treatment.

Purpose of the Study:

  • To investigate the pharmacokinetics and pharmacodynamics of bacterially synthesized GM-CSF.
  • To explore the relationship between GM-CSF administration methods and patient response.
  • To identify factors influencing GM-CSF efficacy and toxicity.

Main Methods:

  • 33 patients received GM-CSF (0.3-30 micrograms/kg/d) subcutaneously or intravenously for 10 days.
  • Serum GM-CSF levels were measured using enzyme-linked immunosorbent assay (ELISA).
  • Correlations between pharmacokinetic variables, efficacy, and toxicity were analyzed.

Main Results:

  • Subcutaneous administration of GM-CSF appeared more effective than intravenous.
  • Patient response correlated with dose, duration of GM-CSF levels above 1 ng/ml, and area under the concentration-time curve.
  • First-dose reactions were associated with high peak serum levels (Cmax) and intravenous administration.
  • Fever, liver enzyme elevation, and pericarditis occurred at higher doses (10-30 micrograms/kg) regardless of administration route.

Conclusions:

  • The therapeutic index of GM-CSF can be improved by optimizing the administration method.
  • Different pharmacokinetic variables influence GM-CSF efficacy and toxicity.
  • Tailoring GM-CSF administration based on patient factors and desired outcomes is recommended.

More Related Videos

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development07:02

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development

Published on: February 11, 2019

Lumbar Intrathecal Injection of SOD1-ASOs for Precise CNS Targeting and Predictive Efficacy in Human SOD1-G93A ALS Mice04:41

Lumbar Intrathecal Injection of SOD1-ASOs for Precise CNS Targeting and Predictive Efficacy in Human SOD1-G93A ALS Mice

Published on: February 24, 2026

Related Concept Videos

Indirect-Acting Cholinergic Agonists: Pharmacokinetics01:22

Indirect-Acting Cholinergic Agonists: Pharmacokinetics

Indirect-acting cholinergic agonists, or anticholinesterases, enhance the body's cholinergic activity by inhibiting acetylcholine's breakdown. They are categorized as reversible or irreversible agents based on their mechanism of action. They are further classified into short-acting, intermediate-acting, and long-acting agents based on their duration of action.
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they are...
Drug Delivery: Parenteral Route01:29

Drug Delivery: Parenteral Route

The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...